Key Findings
The North America irritable bowel syndrome treatment market is forecasted to grow with a CAGR of 6.36%, over the studied period. The region’s market growth is attributable to factors, such as the increased incidence of irritable bowel syndrome and the surging population base exhibiting a higher prevalence of gastrointestinal conditions.

Market Insights
The North America irritable bowel syndrome treatment market growth assessment includes the analysis of Canada and the United States. Irritable bowel syndrome is a common disorder affecting the large intestine. Its symptoms and signs include, gas, diarrhea, constipation, cramping, bloating, and abdominal pain. Canada has one of the highest incidence rates of irritable bowel syndrome, across the world, with nearly 5 million Canadians suffering from the condition. Since irritable bowel syndrome typically affects more women than men, certain medications are particularly offered to women. Besides, the condition’s sex ratio in the country is seven females to two males.
On the other hand, numerous drugs are prescribed for the treatment of irritable bowel syndrome, in addition to lifestyle and physiological changes, as well as dietary intakes. Moreover, the growing population depicting an increased prevalence of gastrointestinal ailments also plays a crucial role in augmenting the market in Canada. As a result, the increased number of treatments, coupled with the growing occurrence of gastrointestinal diseases, is expected to propel the country’s market growth during the forecast period.

Competitive Insights
Some of the leading companies operating in the market include, Ardelyx Inc, Sebela Pharmaceuticals Inc, Abbott Laboratories, Johnson & Johnson, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments